Head to head
Silicon Laboratories vs NVIDIA
Side-by-side on the measures that matter, with a plain-English read. Full detail: SLAB · NVDA
SLAB
Silicon Laboratories
220.21-0.60%
1-year price shape — +90% over the period
Quant Rating C · 96/100
vs
NVDA
NVIDIA
125.53-14.01%
1-year price shape — -30% over the period
Quant Rating E · 13/100
1-year performance, rebased to 100
NVIDIA edges it on the scoreable measures. NVIDIA pays the highest dividend yield; NVIDIA earns the most per share.
| SLAB | NVDA | |
|---|---|---|
| Snapshot | ||
| Sector | Semiconductors | -- |
| Last price | 220.21 | 125.53 |
| Change today | -0.60% | -14.01% |
| 1-year return | +89.7% | -30.4% |
| Market cap | $7.35B | $3.03T |
| 52-week range | 119.81 – 223.50 | 124.50 – 243.37 |
| Valuation | ||
| P/E (TTM) | -367.02 | 13.48 |
| P/E percentile, own 5-yr range | 0th | 0th |
| P/B | 6.53 | 11.34 |
| Dividend yield | 0.00% | 0.41% |
| Profitability & growth | ||
| EPS (TTM) | -1.98 | 4.90 |
| Net profit (TTM) | $-66.10M | $118.09B |
| Revenue (TTM) | $900.79M | $302.97B |
| Provider revenue period date | 2026-10-02 | 2026-07-25 |
| Revenue growth (YoY) | +21.8% | +105.9% |
| Gross margin | 61.3% | 74.7% |
| Operating margin | -2.6% | 65.2% |
| Net margin | -2.3% | 63.7% |
| Free cash flow (TTM) | $7.10M | $127.01B |
| Provider cash-flow period date | 2026-10-02 | 2026-07-25 |
| Ownership & sentiment | ||
| Institutional ownership | 92.7% | 70.2% |
| Insider activity (12mo) | 27 buy / 23 sell | 13 buy / 36 sell |
| Short interest (% of float) | 5.1% | 1.2% |
| Analyst consensus | 100% hold (1) | 67% buy / 30% hold / 2% sell (43) |
| Analyst price target | $231 (+5%) | $233 (+86%) |
| StockVane view | ||
| StockVane Quant Rating | C (96) | E (13) |
| Company | ||
| Employees | 1,930 | 42,000 |
| Founded | 1996 | 1993 |
▲ marks the more favourable stock(s) on measures with a clear direction (lower P/E, higher yield, higher Quant Rating, better 1-year return). Analyst consensus counts each covering institution once, at its most recent rating. Not a recommendation. Quant Rating method: Data & Methodology.